Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium
Y. Fujii et al., Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium, UROL INTERN, 64(3), 2000, pp. 129-133
Objective: To assess the contribution of the carbohydrate antigens, sialyl-
Lewis X (sLe(x)) and sialyl-lewis A (sLe(a)), which are known to be ligands
for E-selectin, to the adhesion between human urothelial cancer cells and
cytokine-activated human endothelial cells. Materials and Methods: We studi
ed the expression of sLe(x) and sLe(a) antigens of three bladder cancer cel
l lines (JTC 30, JTC 32, and T24) by flow cytometry and the adherence to in
terleukin 1 beta-activated human umbilical vein endothelial cells (HUVEC).
Results: JTC 30 and JTC 32 cells expressed both sLe(x) and sLe(a) antigens,
and showed adhesion to activated HUVEC, which was completely abolished by
anti-E-selectin antibody. 124 cells expressed neither sLe(x) nor sLe(a) ant
igen, and did not adhere to activated HUVEC. Each of anti-sLe(a) or anti-sL
e(x) antibody partially blocked the attachment of JTC 30 cells to activated
HUVEC, and combination of these antibodies almost completely blocked the a
dhesion. The combination of antibodies did not significantly influence the
adhesion of JTC 32 cells. Conclusion: These results indicate that both sLe(
a) and sLe(x) carbohydrate antigens are involved in E-selectin-mediated adh
esion of some urothelial cancers, and that there might be unknown ligands f
or E-selectin on urothelial cancer cells. Copyright (C) 2000 S. Karger AG.
Basel.